HLA-DR Monoclonal Antibody (TU36), PE-Texas Red
PRODUCT DETAILS
Host: Mouse
Isotype: IgG2b
Clonality: Monoclonal
Clone: TU36
Format: PE-Texas Red
Reactivity: Hu
Application: Flow Cytometry
Tested Dilution: Assay-Dependent
Concentration:
Storage: 4°C, store in dark
Formulation: PBS with 10% sucrose, BSA and 0.1% sodium azide
Purification: purified
Data Sheet: TDS
Specific Information
The R-phycoerythrin (PE)-Texas Red conjugate permits simultaneous multicolor labeling and detection of multiple targets with excitation by a single excitation source-the 488 nm line of the argon-ion laser.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
PRODUCT DETAILS
Host: Mouse
Isotype: IgG2b
Clonality: Monoclonal
Clone: TU36
Format: PE-Texas Red
Reactivity: Hu
Application: Flow Cytometry
Tested Dilution: Assay-Dependent
Concentration:
Storage: 4°C, store in dark
Formulation: PBS with 10% sucrose, BSA and 0.1% sodium azide
Purification: purified
Data Sheet: TDS
Specific Information
The R-phycoerythrin (PE)-Texas Red conjugate permits simultaneous multicolor labeling and detection of multiple targets with excitation by a single excitation source-the 488 nm line of the argon-ion laser.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Original: $586.00
-70%$586.00
$175.80Description
PRODUCT DETAILS
Host: Mouse
Isotype: IgG2b
Clonality: Monoclonal
Clone: TU36
Format: PE-Texas Red
Reactivity: Hu
Application: Flow Cytometry
Tested Dilution: Assay-Dependent
Concentration:
Storage: 4°C, store in dark
Formulation: PBS with 10% sucrose, BSA and 0.1% sodium azide
Purification: purified
Data Sheet: TDS
Specific Information
The R-phycoerythrin (PE)-Texas Red conjugate permits simultaneous multicolor labeling and detection of multiple targets with excitation by a single excitation source-the 488 nm line of the argon-ion laser.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
